Impaired regulatory T-cell function results in a severe chronic autoimmune disease affecting multiple organs in Scurfy mice and humans with the immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome. Previous studies have shown that T helper cells but not cytotoxic T cells are critical for the disease pathology. Whether this T-cell subset is responsible directly for tissue inflammation or rather indirectly via the interaction with B cells or myeloid cells is largely unknown. To study this and to identify potential therapeutic targets for this lethal disease we investigated the contribution of B cells to this complex autoimmune phenotype. We show that B cells and the production of autoantibodies plays a major role for skin, liver, lung, and kidney inflammation and therapeutic depletion of B cells resulted in reduced tissue pathology and in prolonged survival. In contrast, the absence of B cells did not impact systemic T-cell activation and hyperreactivity, indicating that autoantibody production by B cells may be a major factor for the autoimmune pathology in mice deficient for regulatory T cells.
Impaired regulatory T-cell function results in a severe chronic autoimmune disease affecting multiple organs in Scurfy mice and humans with the immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome. Previous studies have shown that T helper cells but not cytotoxic T cells are critical for the disease pathology. Whether this T-cell subset is responsible directly for tissue inflammation or rather indirectly via the interaction with B cells or myeloid cells is largely unknown. To study this and to identify potential therapeutic targets for this lethal disease we investigated the contribution of B cells to this complex autoimmune phenotype. We show that B cells and the production of autoantibodies plays a major role for skin, liver, lung, and kidney inflammation and therapeutic depletion of B cells resulted in reduced tissue pathology and in prolonged survival. In contrast, the absence of B cells did not impact systemic T-cell activation and hyperreactivity, indicating that autoantibody production by B cells may be a major factor for the autoimmune pathology in mice deficient for regulatory T cells. R egulatory T cells (Treg) are critical for the maintenance of immunological tolerance (1) (2) (3) . The transcription factor FoxP3 is critical for the development of functional Tregs and mutations affecting FoxP3 function result in a loss of immunological tolerance in mice and humans (4) (5) (6) (7) . The resulting chronic autoimmune phenotype in Scurfy mice and in human patients with the immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome is characterized by infiltrations of activated immune cells consisting of B cells, T cells, dendritic cells, monocytes, and eosinophils into several organs such as the skin, lung, kidney, and the liver, ultimately leading to organ failure and the premature death of affected individuals (3, 5, 8, 9) . The only curative therapy for human IPEX patients so far is allogeneic stem cell transplantation, which in many cases is hampered by the bad overall health of affected patients (10) . Thus, therapeutic strategies that can ameliorate systemic inflammation and organ damage would allow a window of time to be created for hematopoietic stem cell transplantation. In mice, this autoimmune phenotype can be recapitulated by the deletion of Tregs after birth (11, 12) . The adoptive transfer of Tregs can rescue this phenotype and transfer of T cells depleted for the CD4/CD25
high Treg population into T-cell-deficient animals induces a Scurfy-like phenotype, providing strong evidence for the crucial role of Tregs for the maintenance of immunological tolerance (11, (13) (14) (15) (16) . Previous studies have shown that deletion of cytotoxic T cells has no effect on the disease phenotype, whereas removal of T helper cells and most forward the deletion of the costimulatory molecule CD28 leads to improved survival of the animals (17, 18) . Further evidence suggesting that the interaction of CD28 or its inhibitory counterpart CTLA4 with the costimulatory molecules CD80 or CD86, which are expressed on activated antigen-presenting cells, are essential in maintaining immune homeostasis is provided by the Scurfy-like phenotype developing in cytotoxic T-lymphocyte antigen 4 (CTLA4)-deficient mice (19, 20) . Besides CD28, a variety of cytokine gene knockouts were bred to the Scurfy background indicating that especially IL2 may be critical for skin inflammation. In contrast, neither IL2, IL4, IL10, INF-γ, or signal transducer and activator of transcription (Stat6) signaling was required for liver inflammation (21) . Besides professional antigen-presenting cells such as dendritic cells, activated B cells also express CD80 and CD86 and may be involved in the hyperactive T-cell phenotype and responsible for the elevated cytokine levels observed in Scurfy mice and human IPEX patients. Indeed, it was shown that B-cell tolerance is lost in Scurfy mice resulting in altered B-cell development, hyperimmunoglobulinemia, and autoantibody production, which may also contribute to tissue inflammation and recruitment of innate immune-effector cells (9, (22) (23) (24) (25) . More recently, a regulatory T-follicular helper cell subset was suggested to directly modulate germinal center reaction of B cells, which may explain at least in part the aberrant expansion of late B-cell developmental stages in Scurfy mice (26) . To investigate which role B cells and the production of autoantibodies play in the Scurfy autoimmune phenotype, we generated B-cell-deficient Scurfy mice. We show that in the absence of B cells and autoantibodies the majority of autoimmune phenotypes are strongly reduced resulting in prolonged survival. Reconstitution of B-celldeficient Scurfy mice with mature splenic B cells from wild-type mice reconstituted the disease phenotype and reduced survival. In contrast, the absence of B cells had no effect on T-cell activation and only minor effects on cytokine production, suggesting
Significance
The deficiency of regulatory T cells leads to a fatal systemic autoimmune disease in mice (Scurfy phenotype) and humans [IPEX (immune dysregulation, polyendocrinopathy, enteropathy, X-linked) syndrome]. At present it is largely unclear to what degree the different deregulated parts of the immune system contribute to the disease pathology. To understand the role of B cells and the corresponding autoantibodies produced by these cells in this fatal disease we generated B-cell-deficient Scurfy mice and show that most of the systemic autoimmune phenotypes are greatly ameliorated. Consistent with this genetic approach, therapeutic depletion of B cells resulted in a similar increase in survival and reduction in multiorgan inflammation, suggesting that B cells may be a therapeutic target to ameliorate disease pathology. that B cells may mainly contribute to tissue inflammation via the production of a wide array of autoantibodies.
Results and Discussion
Loss of Humoral Tolerance in Scurfy Mice. To verify the loss of humoral tolerance in Scurfy mice we first analyzed the level of serum immunoglobulins and the presence of autoantibodies in hemizygous males affected by the disease. Indeed, we noted a pronounced hyperglobulinemia in IgM, IgG1, IgG3, IgA, and IgE subclasses and a higher level of Ig-secreting cells in the spleen, lymph nodes, and bone marrow (Fig. S1 A-D) . More importantly, autoantibodies specific for double-stranded DNA, glucose-6-phosphate isomerase, and skin antigens were present in these animals, and Ig and complement deposits were detectable in the kidneys of Scurfy mice ( Fig. 1 A-F) . Furthermore, increased levels of IgM and IgG antibodies could be detected on platelets of Scurfy mice, which may either represent plateletspecific antibodies or immune complexes deposited on the platelet surface (Fig. 1C) . Consistent with the presence of these antibodies, Scurfy mice showed a pronounced immunothrombocytopenia (ITP) (Fig. 1D) . We could further detect Ig-producing B cells and lymphoid like structures in the liver, suggesting that at least some of these Ig deposits may be caused by B cells present in these organs (Fig. S2) .
Absence of B Cells Ameliorates Chronic Inflammation and Prolongs
Survival. To investigate to what extent B cells and the respective autoantibodies are responsible for the different inflammatory phenotypes and the reduced survival, we generated B-celldeficient Scurfy mice by crossing Scurfy mice to μMT animals. The resulting mice were deficient in peripheral B cells and did not produce immunoglobulins ( Fig. S3 A and B) . Of note, B-celldeficient Scurfy mice had an increased body weight compared with their B-cell-sufficient littermates and did not show the splenomegaly typically observed in Treg-deficient animals (Figs. 2 A and B). As Scurfy mice deficient in CD4 T cells still had a splenomegaly these results indicate that B cells, although present at reduced numbers in Scurfy mice, are a major cause for the increased spleen size (17) . Moreover, kidney function was restored and the severe immunothrombocytopenia was absent in B-celldeficient Scurfy mice ( Fig. 2 C-E). In a similar manner, the inflammatory infiltrate in the liver consisting of activated innate and adaptive immune cells was strongly reduced and contained lower amounts of activated cells (Fig. 2 F and G) . Despite this reduction, lymphoid like structures consisting of dendritic cells and T cells were still detectable in the liver (Fig. S2C ). Another characteristic feature of Scurfy mice is a severe skin and lung inflammation. B-cell-deficient Scurfy animals showed a strong amelioration in skin and lung inflammation evident by a reduced skin thickness and an absent inflammatory infiltrate in both organs, suggesting that autoantibodies directed for example against skin antigens, such as keratin-14 or BP180, which have been identified in Scurfy mice and human IPEX patients, are indeed a major driver of inflammation (Figs. 1F and 2 H-J) (22) . Consistent with this reduction in systemic inflammation and organ damage, B-celldeficient Scurfy mice showed an approximately threefold increased average survival with individual mice living up to 200 d (Fig. 2K) . /BoyJ mice into B-cell-deficient wild-type and Scurfy animals. A strong increase in the development of CD138-positive plasma cells or plasma blasts was evident on the Scurfy background and coincided with the production of autoantibodies and the presence of IgG1, IgM, and IgE deposits in the kidneys (Fig. 3 A-C). In a similar manner, a strong trend toward an increase in liver inflammation was evident and the reconstitution with B cells resulted in a significant reduction in survival of B-cell-deficient Scurfy mice (Fig. 3 D-F) . This may indicate that B cells and In all experiments 4-wkold male C57BL/6 wild-type (XY) and Scurfy (XYsf) animals were analyzed. Shown is one representative out of three independent experiments. Statistical analysis was performed with the Mann-Whitney test (nonparametric). *P < 0.05, **P < 0.01, ***P < 0.001, ns: no significant difference.
the corresponding production of autoantibodies could indeed be directly responsible for a large portion of the autoimmune phenotype in Scurfy mice.
Therapeutic Depletion of B Cells Interferes with Autoimmunity and
Prolongs Survival. To test if depleting B cells may be a therapeutic avenue to ameliorate systemic inflammation we treated Scurfy mice starting from the day of birth with a CD20-specific B-celldepleting antibody (27) . This resulted in a strong reduction of serum antibodies consistent with the mitigated level of CD138-positive plasma blasts or plasma cells (Fig. 4 A and B) . As in B-cell-deficient mice, a complete normalization of platelet counts and an absent Ig deposition in the kidneys of treated animals could be observed (Fig. 4 C and D) . In line with this reduced systemic autoimmune phenotype, Scurfy mice treated with this B-cell-depleting antibody showed a survival comparable to that of μMT/μMT-Scurfy mice (Fig. 4E) . Apart from the production of autoantibodies, B cells may also be involved in maintaining chronic T-cell activation via the provision of costimulatory signals including CD40, CD80, and CD86. Indeed, previous studies demonstrated an up-regulation of these molecules on B cells in Scurfy mice (18) . To assess if B cells are indeed critical for T-cell activation, we analyzed the activation status of the T-cell compartment in Scurfy and B-cell-deficient Scurfy animals. As shown in Fig. S4 , no difference in the amount of activated central and effector memory T cells was detectable between the two groups of mice, suggesting that B cells are at least not the only factor responsible for chronic T-cell activation in Scurfy mice. Consistent with this finding, no major change in the heightened cytokine levels in the serum of Scurfy mice was detectable in the absence of B cells, with the notable exception of the significantly reduced levels of IL-6 (Fig. S5) . As neither Scurfy mice deficient in IL6 or treated with an anti-IL6 antibody showed a reduced level of autoimmune pathology it seems unlikely, however, that this reduction in IL6 contributed to the amelioration of autoimmune pathology (25) . To further establish if T-cell-dependent activation of B cells is a major driver for Bcell activation and autoantibody production, we generated MHC class II deficient Scurfy mice. As shown in Fig. 5 A-H these mice were devoid of serum antibodies, had no ITP, a normal kidney function, and strongly reduced cell infiltrations in the lung and the liver. Moreover, the survival of these mice was increased to a comparable level as in B-cell-deficient Scurfy mice (Fig. 5I) . In a similar manner, the transfer of MHC class II deficient B cells into μMT/μMT Scurfy mice did not result in Ig production suggesting that autoantibody production by B cells is strictly dependent on T helper cells in Scurfy mice (Fig. S6) . Taken together, this study strongly supports the notion that B cells and the corresponding autoantibodies are major contributors to the severe autoimmune phenotype and premature death observed in Scurfy mice. In the absence of B cells and autoantibodies the size of the inflammatory infiltrates in peripheral organs was reduced and contained lower amounts of activated cells. Transfer of splenic B cells from wild-type mice into B-cell deficient Scurfy animals restored the autoimmune phenotype, which suggests that Tregs are critical to maintain humoral tolerance in the periphery. This may be either achieved by preventing the expansion of autoreactive B cells, which had . Shown is one out of three independent experiments for A-D; *P < 0.05, **P < 0.01, ***P < 0.001.
autoantibody response (23) (24) (25) 28) . A potential clinical relevance for our observations is highlighted by the fact that depletion of B cells in affected Scurfy mice resulted in a reduction of inflammation and a prolonged survival. To our knowledge, there is only one case study in human IPEX patients so far, showing that the skin phenotype was ameliorated under B-cell depletion therapy in one treated IPEX patient (29) . Although this is not direct proof that B-cell depletion may have a therapeutic benefit in human IPEX patients, it at least suggests that autoantibody production by B cells also contributes to the disease phenotype in humans. Despite this general improvement of the autoimmune phenotype it should be noted that even B-cell-deficient Scurfy mice eventually died, suggesting that other antibody independent pathways are critical for the full-blown autoimmune phenotype. This is in line with studies showing that the transfer of T helper cells depleted for Tregs into B-and T-cell-deficient recombination activating gene (Rag) −/− mice can induce a Scurfy-like autoimmune pathology (30) . Apart from B cells, T cells, and T-cell-derived cytokines are also critical to control the activation of innate immune effector cells, such as monocytes and macrophages, which might be responsible for the delayed inflammation and the death of affected animals (21) . Further studies designed to analyze the mechanism of B-cell independent induction of autoimmune pathology will be necessary to understand this in more detail.
Experimental Procedures
Animals. B6.SJL-Ptprc a Pepc b /BoyJ, Scurfy, μMT, and MHC class II knockout mice were purchased from the Jackson Laboratories. Scurfy mice were bred with μMT and MHC class II knockout mice to generate B-cell and MHC class II deficient Scurfy mice (μMT −/− and MHCII −/− Scurfy mice, respectively). All mice were held under specific pathogen-free conditions and in isolated ventilated cages in the animal facilities of the University of Erlangen, according to state and institutional guidelines and the rules and regulations of the German animal welfare laws.
ELISpot Analysis. ELISpot plates (Millipore) were activated with 70% ethanol for 1 min. After washing, membranes were coated with the 2 μg/mL goat antimouse IgM/G/E antibodies (Jackson Immuno Research) in Tris/EDTA (TE) buffer at 4°C overnight. Membranes were washed with PBS and blocked with PBS/2% FCS for 2 h at room temperature; 20,000 cells from spleen, lymph node, or bone marrow were seeded in four replicates in RPMI/10% FCS/1% Penicillin/Streptomycin/1% nonessential amino acids/1% sodium pyruvate/1% glutamate and incubated for 2hrs at 37°C and 5% CO 2 . Ig-Spots were detected by incubation with peroxidase conjugated goat anti-mouse IgM/G/E antibodies (Bethyl XYsf) mice. Statistical analysis was performed with the Mann-Whitney test (nonparametric). Error bars represent the mean ± SEM. *P < 0.05, **P < 0.01, ***P < 0.001.
Determination of the Platelet Count. Platelet counts were determined in blood diluted in PBS and 5% BSA (1:2 to1:10 dilution) and analyzed in an Advia 120 hematology system (Siemens) as described (27) .
ELISA. Sera of 4-wk-old mice were collected and stored at −80°C until further use. For quantification of the serum concentration of different Ig isotypes the corresponding Bethyl Mouse ELISA Quantification Kit (Biomol) was used according to the manufacturer´s instructions. The optical density (OD) was measured with a VersaMax tunable microplate reader (Molecular Devices) at 450 and 650 nm. For the detection of anti-DNA antibodies, ELISA plates were coated with 10 μg/mL methylated BSA (Sigma) in PBS for 2 h at room temperature. After washing, the plates were coated with 50 μg/mL calf thymus DNA (Sigma) in PBS at 4°C overnight. Blocking of unspecific binding was performed with PBS/0.1% Gelatin/3% BSA/1 mM EDTA. Sera were diluted 1:100 in the blocking solution and incubated for 1 h at room temperature. As a detection antibody, the HRP-conjugated IgM and IgG1 antibodies (Bethyl) were used at a dilution of 1:20,000 in blocking solution. For detection 3,3`,5,5`-tetramethylbenzidin-peroxidase substrate (TMB Solution, Sigma) was added and the reaction was stopped with 6% orthophosphoric acid. To detect GPI-specific antibodies, ELISA plates were coated with 1 μg/ mL GPI in PBS at 4°C overnight. Blocking was performed with PBS/3% BSA for 1 h at room temperature. Sera were diluted 1:100 in PBS/3% BSA and incubated 1 h at room temperature. Detection antibody was diluted 1:20,000 in PBS/3% BSA for 1 h at room temperature. Detection of bound mouse antibodies was performed as described for the anti-dsDNA ELISA. Rheumatoid factor was detected by coating 1 ng/mL mouse IgG2a on ELISA plates overnight at 4°C. Unspecific binding was blocked with PBS/3% BSA for 1 h at room temperature. Sera were diluted 1:100 in PBS/3% BSA and incubated for 1 h at room temperature and detection of bound antibodies was carried out as described before. Anti-BP180 specific antibodies were identified by coating 5 μg/mL murine collagen 17 protein (kindly provided by Prof. Detlef Zillikens, University of Lübeck) on ELISA plates overnight at 4°C. Nonspecific binding was blocked with PBS/1%BSA for 1 h at room temperature. Sera were diluted 1:100 in PBS/1% BSA and incubated for 1 h at room temperature and detection of bound antibodies was carried out as described before.
Detection of Anti-Nuclear Antibodies. Autoantibodies specific for nuclear antigens were detected on HEp-2 slides (Viro-Immun). Experiments were carried out using the manufacturer's recommended protocol using serum diluted in PBS at 1:100 followed by detection with an FITC-conjugated antimouse IgM (clone AF6-78; Biolegend) and anti-mouse IgG1 (clone A85-1; BD Pharmingen) secondary antibody. Slides were mounted using Fluoromount imaging medium (Sigma) and analyzed on a Zeiss AxioVert system with the Axiovision 4.8 software. Images were taken using a 100x oil immersion lens. CD20-Antibody Production and B-Cell Depletion. CD20-IgG2a was produced by transient calcium phosphate transfection of 293 T cells followed by purification of the secreted antibody from the culture supernatant using protein G as described (27) . B-cell depletion was achieved by weekly injections of 100 μg of the antibody starting from the day of birth.
Detection of Platelet-Specific Antibodies. Anti-platelet (PLT) antibodies in the sera of Scurfy mice were detected using flow cytometry analysis. PLT were enriched from C57BL/6 whole-blood samples by centrifugation (300 g for 5 min). Supernatant was mixed with PBS and centrifuged for an additional 15 min at 1,500 g. Pellet was washed (15 min; 1,500 g). Erythrocytes were removed by centrifugation (10 min, 100 g). PLT in the supernatant were incubated on ice with sera from Scurfy or wild-type mice for 15 min, followed by washing and further incubation with combinations of the following antibodies: anti-CD61 (clone 2C9.G2; Biolegend), anti-IgM (clone AF6-78; Biolegend), or anti-IgG1 (clone A85-1; BD Pharmingen) and analyzed on a FACS Canto II (BD Bioscience).
Statistical Analysis. Statistical differences between experimental groups were calculated with the Mann-Whitney u test. Differences in survival were analyzed with Kaplan-Meier estimates, and groups were compared with the log rank test; P < 0.05 was considered significant.
